155 related articles for article (PubMed ID: 38286404)
1. Identification of a Biomarker Panel from Genome-Wide Methylation to Detect Early HPV-Associated Oropharyngeal Cancer.
Dickey BL; Putney RM; Schell MJ; Berglund AE; Amelio AL; Caudell JJ; Chung CH; Giuliano AR
Cancer Prev Res (Phila); 2024 Apr; 17(4):169-176. PubMed ID: 38286404
[TBL] [Abstract][Full Text] [Related]
2. Methylation of HPV 16 and EPB41L3 in oral gargles: Associations with oropharyngeal cancer detection and tumor characteristics.
Giuliano AR; Nedjai B; Lorincz AT; Schell MJ; Rahman S; Banwait R; Boulware D; Sirak B; Martin-Gomez L; Abrahamsen M; Isaacs-Soriano KA; Wenig B; Chung CH; Caudell J
Int J Cancer; 2020 Feb; 146(4):1018-1030. PubMed ID: 31304592
[TBL] [Abstract][Full Text] [Related]
3. Methylation of HPV16 and EPB41L3 in oral gargles and the detection of early and late oropharyngeal cancer.
Dickey BL; Nedjai B; Preece MD; Schell MJ; Boulware D; Whiting J; Sirak B; Abrahamsen M; Isaacs-Soriano KA; Kennedy K; Chung CH; Giuliano AR
Cancer Med; 2022 Oct; 11(20):3735-3742. PubMed ID: 35619332
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
Dahlstrom KR; Anderson KS; Field MS; Chowell D; Ning J; Li N; Wei Q; Li G; Sturgis EM
Cancer; 2017 Dec; 123(24):4886-4894. PubMed ID: 28898394
[TBL] [Abstract][Full Text] [Related]
5. Salivary micro RNAs as biomarkers for oropharyngeal cancer.
Ekanayake Weeramange C; Tang KD; Barrero RA; Hartel G; Liu Z; Ladwa R; Langton-Lockton J; Frazer I; Kenny L; Vasani S; Punyadeera C
Cancer Med; 2023 Jul; 12(14):15128-15140. PubMed ID: 37278132
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel methylation markers in HPV-associated oropharyngeal cancer: genome-wide discovery, tissue verification and validation testing in ctDNA.
Misawa K; Imai A; Matsui H; Kanai A; Misawa Y; Mochizuki D; Mima M; Yamada S; Kurokawa T; Nakagawa T; Mineta H
Oncogene; 2020 Jun; 39(24):4741-4755. PubMed ID: 32415241
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study.
D'Souza G; Tewari SR; Troy T; Waterboer T; Struijk L; Castillo R; Wright H; Shen M; Miles B; Johansson M; Robbins HA; Fakhry C
Cancer; 2023 Aug; 129(15):2373-2384. PubMed ID: 37032449
[TBL] [Abstract][Full Text] [Related]
10. Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium.
Robbins HA; Ferreiro-Iglesias A; Waterboer T; Brenner N; Nygard M; Bender N; Schroeder L; Hildesheim A; Pawlita M; D'Souza G; Visvanathan K; Langseth H; Schlecht NF; Tinker LF; Agalliu I; Wassertheil-Smoller S; Ness-Jensen E; Hveem K; Grioni S; Kaaks R; Sánchez MJ; Weiderpass E; Giles GG; Milne RL; Cai Q; Blot WJ; Zheng W; Weinstein SJ; Albanes D; Huang WY; Freedman ND; Kreimer AR; Johansson M; Brennan P
J Clin Oncol; 2022 Nov; 40(31):3613-3622. PubMed ID: 35700419
[TBL] [Abstract][Full Text] [Related]
11. Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV-related oropharyngeal cancer and cancer of unknown primary.
Tanaka H; Suzuki M; Takemoto N; Fukusumi T; Eguchi H; Takai E; Kanai H; Tatsumi M; Horie M; Takenaka Y; Yachida S; Inohara H
Int J Cancer; 2022 Jan; 150(1):174-186. PubMed ID: 34486724
[TBL] [Abstract][Full Text] [Related]
12. Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer.
Drake VE; Fakhry C; Windon MJ; Stewart CM; Akst L; Hillel A; Chien W; Ha P; Miles B; Gourin CG; Mandal R; Mydlarz WK; Rooper L; Troy T; Yavvari S; Waterboer T; Brenner N; Eisele DW; D'Souza G
Cancer; 2021 Apr; 127(7):1029-1038. PubMed ID: 33426652
[TBL] [Abstract][Full Text] [Related]
13. HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status.
Anderson KS; Dahlstrom KR; Cheng JN; Alam R; Li G; Wei Q; Gross ND; Chowell D; Posner M; Sturgis EM
Oral Oncol; 2015 Jul; 51(7):662-7. PubMed ID: 25957822
[TBL] [Abstract][Full Text] [Related]
14. Control of Epstein-Barr Virus (EBV) in the Oral Cavity Is Associated With Persistence of Oral Human Papillomavirus (HPV)16/18 Among Men From the HPV Infection in Men Study.
Dickey BL; Giuliano AR; Sirak B; Abrahamsen M; Lazcano-Ponce E; Villa LL; Coghill AE
J Infect Dis; 2023 Jan; 227(2):256-260. PubMed ID: 35679351
[TBL] [Abstract][Full Text] [Related]
15. Identifying epigenetic biomarkers of established prognostic factors and survival in a clinical cohort of individuals with oropharyngeal cancer.
Langdon R; Richmond R; Elliott HR; Dudding T; Kazmi N; Penfold C; Ingarfield K; Ho K; Bretherick A; Haley C; Zeng Y; Walker RM; Pawlita M; Waterboer T; Gaunt T; Smith GD; Suderman M; Thomas S; Ness A; Relton C
Clin Epigenetics; 2020 Jun; 12(1):95. PubMed ID: 32600451
[TBL] [Abstract][Full Text] [Related]
16. Acoustofluidic Salivary Exosome Isolation: A Liquid Biopsy Compatible Approach for Human Papillomavirus-Associated Oropharyngeal Cancer Detection.
Wang Z; Li F; Rufo J; Chen C; Yang S; Li L; Zhang J; Cheng J; Kim Y; Wu M; Abemayor E; Tu M; Chia D; Spruce R; Batis N; Mehanna H; Wong DTW; Huang TJ
J Mol Diagn; 2020 Jan; 22(1):50-59. PubMed ID: 31843276
[TBL] [Abstract][Full Text] [Related]
17. Promoter Hypermethylation of Tumor-Suppressor Genes
Liyanage C; Wathupola A; Muraleetharan S; Perera K; Punyadeera C; Udagama P
Biomolecules; 2019 Apr; 9(4):. PubMed ID: 31013839
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer.
Kreimer AR; Johansson M; Yanik EL; Katki HA; Check DP; Lang Kuhs KA; Willhauck-Fleckenstein M; Holzinger D; Hildesheim A; Pfeiffer R; Williams C; Freedman ND; Huang WY; Purdue MP; Michel A; Pawlita M; Brennan P; Waterboer T
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376197
[TBL] [Abstract][Full Text] [Related]
19. Telomere length in peripheral blood lymphocytes contributes to the development of HPV-associated oropharyngeal carcinoma.
Zhang Y; Sturgis EM; Dahlstrom KR; Wen J; Liu H; Wei Q; Li G; Liu Z
Cancer Res; 2013 Oct; 73(19):5996-6003. PubMed ID: 23928994
[TBL] [Abstract][Full Text] [Related]
20. Screening for HPV-related oropharyngeal, anal, and penile cancers in middle-aged men: Initial report from the HOUSTON clinical trial.
Dahlstrom KR; Anderson KS; Guo M; Kwon MC; Messick CA; Pettaway CA; Asomaning N; Hopper M; Price A; Xu L; Day AT; Gillenwater AM; Sturgis EM
Oral Oncol; 2021 Sep; 120():105397. PubMed ID: 34182223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
